These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30181802)

  • 41. Nomogram for the prediction of triple-negative breast cancer histological heterogeneity based on multiparameter MRI features: A preliminary study including metaplastic carcinoma and non- metaplastic carcinoma.
    Kong QC; Tang WJ; Chen SY; Hu WK; Hu Y; Liang YS; Zhang QQ; Cheng ZX; Huang D; Yang J; Guo Y
    Front Oncol; 2022; 12():916988. PubMed ID: 36212484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new nomogram for predicting the malignant diagnosis of Breast Imaging Reporting and Data System (BI-RADS) ultrasonography category 4A lesions in women with dense breast tissue in the diagnostic setting.
    Yang Y; Hu Y; Shen S; Jiang X; Gu R; Wang H; Liu F; Mei J; Liang J; Jia H; Liu Q; Gong C
    Quant Imaging Med Surg; 2021 Jul; 11(7):3005-3017. PubMed ID: 34249630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of prognostic nomograms using institutional data for patients with triple-negative breast cancer.
    Zhou JY; Lu KK; Fu WD; Shi H; Gu JW; Lu YQ; Guo GL
    Future Oncol; 2021 Dec; 17(36):5077-5091. PubMed ID: 34704816
    [No Abstract]   [Full Text] [Related]  

  • 44. NCCBM, a Nomogram Prognostic Model in Breast Cancer Patients With Brain Metastasis.
    Liu Q; Kong X; Wang Z; Wang X; Zhang W; Ai B; Gao R; Fang Y; Wang J
    Front Oncol; 2021; 11():642677. PubMed ID: 33996557
    [No Abstract]   [Full Text] [Related]  

  • 45. A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With
    Wang Z; Wang H; Sun X; Fang Y; Lu SS; Ding SN; Chen XS; Shen KW
    Front Oncol; 2020; 10():14. PubMed ID: 32038988
    [No Abstract]   [Full Text] [Related]  

  • 46. Nomogram for Predicting Lymph Node Involvement in Triple-Negative Breast Cancer.
    Cui X; Zhu H; Huang J
    Front Oncol; 2020; 10():608334. PubMed ID: 33344259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A nomogram for predicting prognostic value of inflammatory biomarkers in patients with acute-on-chronic liver failure.
    Gong J; Zhou W; Xiao C; Jie Y; Zhu S; Zheng J; Chong Y; Hu B
    Clin Chim Acta; 2018 Mar; 478():7-12. PubMed ID: 29247632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding.
    Hou X; Li X; Han Y; Xu H; Xie Y; Zhou T; Xue T; Qian X; Li J; Wang HC; Yan J; Guo X; Liu Y; Liu J
    Cancer; 2024 Apr; 130(S8):1499-1512. PubMed ID: 38422056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and validation of nomogram based on lncRNA ZFAS1 for predicting survival in lymph node-negative esophageal squamous cell carcinoma patients.
    Shi H; Liu Z; Pei D; Jiang Y; Zhu H; Chen B
    Oncotarget; 2017 Aug; 8(35):59048-59057. PubMed ID: 28938617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic nomogram and score to predict renal survival of patients with biopsy-proven diabetic nephropathy.
    Jiang S; Yu T; Zhang Z; Fang J; Wang Y; Yang Y; Liu L; Zou G; Gao H; Zhuo L; Li W
    Diabetes Res Clin Pract; 2019 Sep; 155():107809. PubMed ID: 31401150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. External Validation of a Nomogram and Risk Grouping System for Predicting Individual Prognosis of Patients With Medulloblastoma.
    Guo C; Yao D; Lin X; Huang H; Zhang J; Lin F; Mou Y; Yang Q
    Front Pharmacol; 2020; 11():590348. PubMed ID: 33343359
    [No Abstract]   [Full Text] [Related]  

  • 52. Development and Validation of a Prognostic Nomogram for HR+ HER- Breast Cancer.
    Zhou JY; Pan CG; Ye Y; Li ZW; Fu WD; Jiang BH
    Cancer Manag Res; 2024; 16():491-505. PubMed ID: 38800665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognosis prediction and risk factors for triple-negative breast cancer patients with brain metastasis: A population-based study.
    Yang Y; Zhang L; Tian W; Li Y; Qin Q; Mao Y; Liu X; Hong J; Hu L; Zeng Q; Zhang Q; Zhao H
    Cancer Med; 2023 Apr; 12(7):7951-7961. PubMed ID: 36629093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and validation of nomograms integrating immune-related genomic signatures with clinicopathologic features to improve prognosis and predictive value of triple-negative breast cancer: A gene expression-based retrospective study.
    Wang K; Li HL; Xiong YF; Shi Y; Li ZY; Li J; Zhang X; Li HY
    Cancer Med; 2019 Feb; 8(2):686-700. PubMed ID: 30677255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and validation of a prognostic nomogram for IgA nephropathy.
    Liu J; Duan S; Chen P; Cai G; Wang Y; Tang L; Liu S; Zhou J; Wu D; Shen W; Chen X; Wu J
    Oncotarget; 2017 Nov; 8(55):94371-94381. PubMed ID: 29212234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Nomogram for the Prediction of Prognosis in Patients With Distant Metastases of Nasopharyngeal Carcinoma.
    Zhao L; Lin Q; Gu J; Zhang H; Chen H; Lin Q
    Front Oncol; 2019; 9():240. PubMed ID: 31024844
    [No Abstract]   [Full Text] [Related]  

  • 58. Nomogram for predicting the risk of bone metastasis in breast cancer: a SEER population-based study.
    Ye LJ; Suo HD; Liang CY; Zhang L; Jin ZN; Yu CZ; Chen B
    Transl Cancer Res; 2020 Nov; 9(11):6710-6719. PubMed ID: 35117281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database.
    Man X; Xu H; Wang H; Zhao J; Chen X; Yin S; Tan Q; Huang J; Sun S; Zhou D; Zheng F; Liu T; Song L; Zhang B; Li N; Li H
    Ann Transl Med; 2022 Dec; 10(24):1351. PubMed ID: 36660717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Prognostic Prediction Value of Systemic Inflammation Score and the Development of a Nomogram for Patients With Surgically Treated Breast Cancer.
    Huang ZZ; Hua X; Song CG; Xia W; Bi XW; Yuan ZY; He ZY; Huang JJ
    Front Oncol; 2020; 10():563731. PubMed ID: 33194636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.